Please ensure Javascript is enabled for purposes of website accessibility

Tag Archives: medimmune

Viela Bio begins clinical trials months after $250M spinoff (access required)

One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela Bio was spun out of MedImmune, a subsidiary of AstraZeneca, last month with $250 million in ...

Read More »

With $250M from investors, Viela Bio out on its own (access required)

MedImmune spun out Viela Bio as an independent biotechnology company with $250 million in Series A financing and six potential medicines, the companies announced Wednesday. Viela Bio will be based in Gaithersburg and will focus on inflammation and autoimmunity biologics, ...

Read More »

Frederick approves MedImmune expansion, road improvements (access required)

FREDERICK — The city of Frederick has finalized a loan package that will approve expansion of MedImmune’s Frederick biotech manufacturing plant and improve roads around the business. The Frederick News-Post reports that the Board of Aldermen voted Thursday to approve ...

Read More »

Plant’s expansion to continue with Md. county’s support (access required)

FREDERICK — The Frederick County Council has voted to financially support the expansion of MedImmune’s Frederick manufacturing plant, a project the company says will bring 300 new jobs. The Frederick News-Post reports that, in a 6-1 vote, the County Council ...

Read More »

MedImmune certified for energy program

Gaithersburg-based MedImmune, the biologics research and development arm of AstraZeneca, has been certified by the Department of Energy’s Superior Energy Performance program for improvements at its headquarters facility. MedImmune is the first company in Maryland  to achieve the certification, the ...

Read More »

MedImmune inks deal (access required)

Gaithersburg-based MedImmune has entered into a three-year partnership with the Clinical and Translational Science Institute at the University of California, San Francisco.

Read More »

AstraZeneca reorganization to cut 1,600 jobs, move 300 to Gaithersburg

TRENTON, N.J. — Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization. The cuts, meant to reduce costs ...

Read More »